After the project of biotransformation, extraction and purification of ginkgo flavone was completed and put into production, the company, in conjunction with Tsinghua University Academy of Life Sciences and Zhejiang Tianzheng Group, focused on the separation and processing technology of ginkgo flavone raw materials and the production technology and technology of the national second-class new drug-One Needle Tong product and Shandong Chuntian Pharmaceutical Project. This project is a high-tech project in the field of biomedicine, with a total investment of 65,438+1billion yuan and an area of 70,000 square meters. Construction began in May 2005. At the same time, according to national standards and universities to build postdoctoral mobile stations. After the project is completed and put into operation in 2007, the industrial output value will increase by 690 million yuan, and the profit and tax will be 654.38+0.5 billion yuan.
The completion of ginkgo flavone extraction production line has greatly improved the processing capacity of ginkgo biloba leaves, which not only completely solved the processing and proliferation of ginkgo biloba leaves in the county, but also promoted the development of ginkgo biloba leaves in surrounding areas, and also promoted the development of related packaging and printing industries. Every year, the company buys all Ginkgo biloba leaves from farmers in Ginkgo biloba base at a higher price according to the contract, which drives the per capita annual income of more than 2,000 local farmers to increase by more than 1 10,000 yuan. It has formed an industrial model of "enterprises connecting bases, bases connecting farmers and supporting production and marketing" and achieved good social, economic and ecological benefits. The county government increased its support for the company and organized the county to promote the intercropping mode of silver (apricot) and grain, which further expanded the planting area of ginkgo biloba and provided rich resources for the next development.